CHURCHILL MANAGEMENT Corp Sells 5,107 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)

CHURCHILL MANAGEMENT Corp trimmed its stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT) by 7.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 59,732 shares of the company’s stock after selling 5,107 shares during the quarter. CHURCHILL MANAGEMENT Corp’s holdings in Cellebrite DI were worth $1,316,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Renaissance Technologies LLC grew its holdings in Cellebrite DI by 22.1% during the 2nd quarter. Renaissance Technologies LLC now owns 1,183,700 shares of the company’s stock valued at $14,145,000 after buying an additional 214,600 shares in the last quarter. Hsbc Holdings PLC boosted its position in shares of Cellebrite DI by 44.7% in the second quarter. Hsbc Holdings PLC now owns 238,002 shares of the company’s stock valued at $2,866,000 after acquiring an additional 73,533 shares during the period. Public Employees Retirement Association of Colorado purchased a new position in Cellebrite DI during the second quarter valued at approximately $71,000. Sei Investments Co. increased its holdings in Cellebrite DI by 16.9% during the 2nd quarter. Sei Investments Co. now owns 141,644 shares of the company’s stock worth $1,693,000 after acquiring an additional 20,478 shares during the period. Finally, Magnetar Financial LLC purchased a new stake in Cellebrite DI in the 2nd quarter worth approximately $143,000. 45.88% of the stock is currently owned by institutional investors.

Cellebrite DI Trading Up 0.3 %

Shares of NASDAQ CLBT opened at $22.98 on Friday. The stock’s 50-day moving average is $20.68 and its 200 day moving average is $17.49. The stock has a market cap of $4.73 billion, a price-to-earnings ratio of -14.83, a P/E/G ratio of 3.18 and a beta of 1.46. Cellebrite DI Ltd. has a 1-year low of $7.91 and a 1-year high of $23.50.

Cellebrite DI (NASDAQ:CLBT) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.09 by $0.05. Cellebrite DI had a negative net margin of 82.28% and a positive return on equity of 122.59%. The firm had revenue of $106.90 million for the quarter, compared to the consensus estimate of $102.06 million. During the same period last year, the firm posted $0.09 earnings per share. The business’s revenue was up 27.0% compared to the same quarter last year. On average, analysts forecast that Cellebrite DI Ltd. will post 0.32 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. TD Cowen upped their price target on shares of Cellebrite DI from $20.00 to $23.00 and gave the stock a “buy” rating in a report on Monday, September 23rd. Craig Hallum upped their target price on Cellebrite DI from $23.00 to $24.00 and gave the stock a “buy” rating in a research note on Thursday, November 7th. JPMorgan Chase & Co. lifted their price target on Cellebrite DI from $22.00 to $24.00 and gave the company an “overweight” rating in a research report on Monday, December 16th. Finally, Needham & Company LLC upped their price objective on shares of Cellebrite DI from $17.00 to $21.00 and gave the stock a “buy” rating in a research report on Thursday, November 7th. Eight analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $20.57.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.